Supernus Pharmaceuticals (SUPN) Files Lawsuit Against Actavis (ACT) Over Trokendi XR Oct 2, 2014 07:35AM

Supernus Pharmaceuticals (Nasdaq: SUPN) announced that earlier today it sued generic drug makers Actavis plc (NYSE: ACT), Actavis, Inc., Actavis Laboratories FL, Inc., Actavis Pharma, Inc., Watson Laboratories, Inc., and Anda, Inc. (collectively "Actavis") for infringement of three patents covering its antiepileptic drug Trokendi XR®. Supernus' United States Patents Nos. 8,298,576, 8,298,580, and 8,663,683 cover once-a-day topiramate formulations and methods of treating seizures using those formulations. Patent protection for Trokendi XR® does not expire until 2029.

The Complaint—filed in the U.S. District Court for the District of New Jersey—alleges that Actavis infringed Supernus' Trokendi XR® patents by submitting to the Food and Drug Administration ("FDA") an Abbreviated New Drug Application ("ANDA") seeking to market a generic version of Trokendi XR® prior to the expiration of Supernus' patents. Filing its Complaint within 45 days of receiving Actavis' Paragraph IV certification notice entitles Supernus to an automatic stay preventing the FDA from approving Actavis' ANDA for 30 months.

Supernus President and CEO Jack Khattar confirmed that "Supernus intends to vigorously enforce its patent rights."

Supernus is represented by attorneys from Frommer Lawrence and Haug LLP and its corporate counsel, Saul Ewing LLP.


WI-LAN (WILN) Reports Apple (AAPL) Granted Motion for Summary Judgement in Pending Litigation Oct 1, 2014 04:15PM

WI-LAN (Nasdaq: WILN) announced that the company had commenced litigation against Apple Inc. (Nasdaq: AAPL), HTC Corporation ("HTC") and Sierra Wireless Inc. (Nasdaq: SWIR) claiming infringement of WiLAN's U.S. Patent Nos. 8,315,640 and 8,311,040, related to LTE technologies.

To date, two of the three defendants, HTC and Sierra Wireless, have signed license and settlement agreements to resolve this litigation. The litigation, involving remaining defendant, Apple, is being tried in the U.S. District Court for the Southern District of California.

Earlier this year, WiLAN moved for summary judgment on invalidity claims. In addition, Apple moved for summary judgment on invalidity and non-infringement defenses. WiLAN has been advised that Judge Dana M. Sabraw has issued a ruling today that grants Apple's motion for summary judgment.

WiLAN is currently reviewing the ruling with trial counsel, McKool Smith. The case remains before the courts and it is WiLAN's policy to not provide commentary on cases that are before the courts.

WiLAN has an additional case in U.S. District Court for the Southern District of California involving Apple related to the infringement of 5 LTE-related patents.


UPDATE: Masimo Corp. (MASI) Wins $466M Verdict in Philips Trial Oct 1, 2014 03:47PM

(Updated - October 1, 2014 3:47 PM EDT)

Masimo Corp. (Nasdaq: MASI) won a $466 million verdict in a trial against Philips (NYSE: PHG), according to Bloomberg.

Masimo sought damages of more than $650 million related to patents on fingertip devices that measure blood oxygen and pulse rates using light absorption.

Shares of Masimo gained about 15 percent on the news.


UPDATE: Masimo Corp. (MASI) Wins $466M Verdict in Philips Trial Oct 1, 2014 03:47PM

(Updated - October 1, 2014 3:47 PM EDT)

Masimo Corp. (Nasdaq: MASI) won a $466 million verdict in a trial against Philips (NYSE: PHG), according to Bloomberg.

Masimo sought damages of more than $650 million related to patents on fingertip devices that measure blood oxygen and pulse rates using light absorption.

Shares of Masimo gained about 15 percent on the news.


Masimo Corp. (MASI) wins $466 million verdict in Philips (PHG) patent trial Oct 1, 2014 03:40PM

Masimo Corp. (NASDAQ: MASI) wins $466 million verdict in Philips (NYSE: PHG) patent trial.


More Litigation

View Older Stories

Oct 1, 2014 10:06AM VirnetX Holding (VHC) Announces Receipt of U.S. Patent Covering Mobile Security
Oct 1, 2014 08:54AM Spherix (SPEX) Announces Rescheduling of Markman Hearing in VTech, Uniden Litigation
Oct 1, 2014 08:44AM Acorn International (ATV) Reports Extraordinary General Meeting Deemed Invalid
Oct 1, 2014 08:03AM Horizon Pharma (HZNP) Reports Receipt of U.S. Patent Related to VIMOVO (POZN)
Oct 1, 2014 07:34AM Keryx Biopharma (KERX) Receives U.S. Patent Covering Hyperphosphatemia Treatment Method
Oct 1, 2014 06:27AM Endo Int'l (ENDP) Enters Additional Settlements in Vaginal Mesh Products Suit
Oct 1, 2014 06:04AM Acacia Research (ACTG) Unit Settles with Liberty Interactive (LINTA)
Sep 30, 2014 01:50PM SEC Charges Two with Insider Trading on Pershing Square's Announcement on Herbalife
Sep 30, 2014 12:53PM UPDATE: FCC Repeals Sports Blackout Rule (DTV)
Sep 30, 2014 11:05AM FCC votes to kill sports blackout rule
Sep 30, 2014 08:13AM ZTE Granted Application to Invalidate Vringo (VRNG) Patent by China's SIPO Board
Sep 30, 2014 07:06AM Can-Fite (CANF) Issued Patent for CF102
Sep 30, 2014 06:44AM U.S. Law Enforcement Aim to Reverse Apple (AAPL), Google (GOOG) User-Privacy Decision
Sep 29, 2014 05:15PM SUPERVALU INC. (SVU) Reports Data Breach
Sep 29, 2014 05:15PM Glatfelter (GLT) Provides Update on Whiting Litigation
Sep 29, 2014 02:18PM Elbit Imaging Ltd (EMITF) Reports PUNTO FA Won't Extend Contract with Elbit Fashion
Sep 29, 2014 01:50PM Flagstar Bancorp (FBC), CFPB Enter Settlement Agreement
Sep 29, 2014 08:56AM Harley-Davidson (HOG) to Recall 100K+ Motorcycles Over Clutch Issue
Sep 26, 2014 11:07AM Microsoft (MSFT) Issues Update on Government Access to Data Reports; Seeks Additional Reforms
Sep 26, 2014 07:53AM AbbVie (ABBV), Abbott (ABT) Win Dismissal of AndroGel, Humira Racketeering Suit
Sep 26, 2014 06:46AM Merrimack Pharma (MACK), PharmaEngine Enter Amended Licensing Agreement for MM-398 (BAX)
Sep 25, 2014 04:48PM Tesla (TSLA) Banned from Allowing Test Drives in Iowa
Sep 25, 2014 04:42PM Medidata Solutions (MDSO) Reports Breach, Money Transfer; Sees Q3 Charge; Will Review Internal Controls
Sep 25, 2014 04:09PM Actavis (ACT) Confirms Butrans Patent Challenge
Sep 25, 2014 03:16PM Apple (AAPL) Sued Over Allegations of Violating 13 SanDisk Patents
Sep 25, 2014 12:08PM Yahoo! (YHOO) Issues Update on Transparency Report
Sep 25, 2014 08:37AM Netlist (NLST) Sued Over Allegations of 'Unfair Business Practices'
Sep 24, 2014 04:42PM Boston Scientific (BSX) Receives Adverse Verdict in Mirowski License Case
Sep 24, 2014 04:36PM Marchex (MCHX) Receives Termination Notice from Allstate (ALL) Over 2014 Call Advertising Services Project
Sep 24, 2014 04:14PM Shire (SHPG) Confirms Agreement to Pay $56.5M to Regulators to Resolve Investigation of Marketing Practices
Sep 24, 2014 01:34PM Vringo (VRNG) Comments on 'Inaccurate Press Release' Issued by ZTE Earlier
Sep 24, 2014 10:02AM VirnetX Holding (VHC) Reports New Security Patent
Sep 24, 2014 08:03AM Regulus Therapeutics (RGLS) Receives USPTO NoA for ETH Zurich Patent Family
Sep 24, 2014 07:07AM Acacia Research (ACTG) Unit, Alarm Lock Systems Enter Patent Litigation Settlement, Licensing
Sep 24, 2014 06:55AM Echo Therapeutics (ECTE) Will Suspend Operations; Aims for Liquidity Conservation
Sep 23, 2014 10:17AM UPDATE: Vringo (VRNG) Gains Following Positive SA Post
Sep 23, 2014 09:04AM PDL BioPharma (PDLI) Says Class Action Suit 'Without Merit'
Sep 23, 2014 06:01AM Acacia Research (ACTG) Unit, Nikon Enter Patent Settlement, License Agreement
Sep 22, 2014 02:02PM Document Security Systems (DSS) Provides Update on IP Enforcement Activity
Sep 19, 2014 03:54PM American Spectrum Realty (AQQ) Submits New Plan of Compliance to NYSE MKT
Sep 19, 2014 03:45PM ITT Educational (ESI) Stock Defended at Wells Fargo
Sep 19, 2014 01:36PM SEC Chargers Man in 'Post-It Notes' Insider Trading Scheme
Sep 19, 2014 09:37AM VirnetX Holding (VHC) Announces Termination of Certain Inter Partes Reexam Proceedings Initiated by Cisco (CSCO)
Sep 18, 2014 04:24PM Home Depot (HD) Updates on Card Breach; Nudges FY14 EPS Outlook Higher
Sep 18, 2014 03:04PM Western Union (WU) Being Probed by SEC
Sep 18, 2014 03:04PM Western Union (WU) Being Probed by SEC
Sep 18, 2014 07:38AM Salix Pharma (SLXP) Receives Exclusive Rights to Rifaximin Patents
Sep 18, 2014 07:18AM USEC (USU) Plans Emergence from Chapter 11 on Sept. 30th
Sep 17, 2014 04:14PM DepoMed (DEPO) Gets Letter from FDA Related to Gralise
View Older Stories